ReviewJournal of personalized medicine2024

Cyclin-Dependent Kinase 4/6 Inhibitors Plus Endocrine Therapy versus Endocrine Therapy Alone for HR-Positive, HER-2-Negative Early Breast Cancer: Meta-Analysis of Phase III Randomized Clinical Trials.

Francisco Cezar Aquino de Moraes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.